DexCom Total Liabilities 2010-2025 | DXCM
DexCom total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- DexCom total liabilities for the quarter ending March 31, 2025 were $4.485B, a 5.9% increase year-over-year.
- DexCom total liabilities for 2024 were $4.382B, a 4.43% increase from 2023.
- DexCom total liabilities for 2023 were $4.196B, a 28.71% increase from 2022.
- DexCom total liabilities for 2022 were $3.26B, a 12.75% increase from 2021.
| DexCom Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $4,382 |
| 2023 | $4,196 |
| 2022 | $3,260 |
| 2021 | $2,891 |
| 2020 | $2,464 |
| 2019 | $1,512 |
| 2018 | $1,253 |
| 2017 | $485 |
| 2016 | $119 |
| 2015 | $71 |
| 2014 | $44 |
| 2013 | $38 |
| 2012 | $29 |
| 2011 | $16 |
| 2010 | $16 |
| 2009 | $65 |
| DexCom Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $4,485 |
| 2024-12-31 | $4,382 |
| 2024-09-30 | $4,375 |
| 2024-06-30 | $4,365 |
| 2024-03-31 | $4,235 |
| 2023-12-31 | $4,196 |
| 2023-09-30 | $4,328 |
| 2023-06-30 | $4,720 |
| 2023-03-31 | $3,283 |
| 2022-12-31 | $3,260 |
| 2022-09-30 | $3,075 |
| 2022-06-30 | $2,962 |
| 2022-03-31 | $2,868 |
| 2021-12-31 | $2,891 |
| 2021-09-30 | $2,640 |
| 2021-06-30 | $2,506 |
| 2021-03-31 | $2,487 |
| 2020-12-31 | $2,464 |
| 2020-09-30 | $2,334 |
| 2020-06-30 | $2,168 |
| 2020-03-31 | $1,513 |
| 2019-12-31 | $1,512 |
| 2019-09-30 | $1,421 |
| 2019-06-30 | $1,378 |
| 2019-03-31 | $1,305 |
| 2018-12-31 | $1,253 |
| 2018-09-30 | $552 |
| 2018-06-30 | $525 |
| 2018-03-31 | $475 |
| 2017-12-31 | $485 |
| 2017-09-30 | $459 |
| 2017-06-30 | $442 |
| 2017-03-31 | $189 |
| 2016-12-31 | $119 |
| 2016-09-30 | $100 |
| 2016-06-30 | $86 |
| 2016-03-31 | $68 |
| 2015-12-31 | $71 |
| 2015-09-30 | $63 |
| 2015-06-30 | $48 |
| 2015-03-31 | $41 |
| 2014-12-31 | $44 |
| 2014-09-30 | $44 |
| 2014-06-30 | $40 |
| 2014-03-31 | $35 |
| 2013-12-31 | $38 |
| 2013-09-30 | $35 |
| 2013-06-30 | $30 |
| 2013-03-31 | $25 |
| 2012-12-31 | $29 |
| 2012-09-30 | $23 |
| 2012-06-30 | $19 |
| 2012-03-31 | $18 |
| 2011-12-31 | $16 |
| 2011-09-30 | $16 |
| 2011-06-30 | $15 |
| 2011-03-31 | $13 |
| 2010-12-31 | $16 |
| 2010-09-30 | $19 |
| 2010-06-30 | $20 |
| 2010-03-31 | $22 |
| 2009-12-31 | $65 |
| 2009-09-30 | $63 |
| 2009-06-30 | $63 |
| 2009-03-31 | $63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $32.690B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.532B | 80.39 |
| Thermo Fisher Scientific (TMO) | United States | $164.157B | 19.86 |
| Edwards Lifesciences (EW) | United States | $45.784B | 30.02 |
| Alcon (ALC) | Switzerland | $43.149B | 29.16 |
| IDEXX Laboratories (IDXX) | United States | $42.895B | 49.29 |
| IQVIA Holdings (IQV) | United States | $28.164B | 15.78 |
| Mettler-Toledo (MTD) | United States | $25.437B | 30.25 |
| STERIS (STE) | Ireland | $22.432B | 24.71 |
| Waters (WAT) | United States | $21.001B | 29.63 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.363B | 0.00 |
| Hologic (HOLX) | United States | $14.645B | 15.91 |
| Sysmex ADR (SSMXY) | Japan | $10.626B | 30.14 |
| Penumbra (PEN) | United States | $9.214B | 72.32 |
| Masimo (MASI) | United States | $8.837B | 32.60 |
| Globus Medical (GMED) | United States | $7.733B | 18.43 |
| Glaukos (GKOS) | United States | $5.932B | 0.00 |
| Teleflex (TFX) | United States | $5.144B | 8.49 |
| Integer Holdings (ITGR) | United States | $4.186B | 21.93 |
| TransMedics (TMDX) | United States | $3.804B | 82.69 |
| PROCEPT BioRobotics (PRCT) | United States | $3.134B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.417B | 14.39 |
| Veracyte (VCYT) | United States | $2.121B | 29.76 |
| Nihon Kohden (NHNKY) | Japan | $1.942B | 22.27 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.606B | 0.00 |
| Artivion (AORT) | United States | $1.343B | 125.84 |
| Pulse Biosciences (PLSE) | United States | $1.078B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.038B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.978B | 5.20 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| IRadimed (IRMD) | United States | $0.732B | 37.14 |
| Semler Scientific (SMLR) | United States | $0.623B | 13.51 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.552B | 8.58 |
| Beta Bionics (BBNX) | United States | $0.549B | 0.00 |
| AxoGen (AXGN) | United States | $0.542B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.532B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.471B | 11.05 |
| Pacific Biosciences Of California (PACB) | United States | $0.441B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.395B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.378B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.377B | 0.00 |
| RxSight (RXST) | United States | $0.325B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| NeuroPace (NPCE) | United States | $0.312B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.236B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Inogen (INGN) | United States | $0.186B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.178B | 0.00 |
| CVRx (CVRX) | United States | $0.178B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.176B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.147B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.117B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| Spectral AI (MDAI) | United States | $0.072B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.068B | 41.60 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.054B | 21.96 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.45 |